Position in PFE
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$31,396,081
-$5,906,963 QoQ
Shares Held
1,303,824
-1.9% QoQ
Ownership
0.023%
of shares outstanding
% of Portfolio
0.15%
of 13F equity value
Holder Rank
#224
of 2,834 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026MetLife Investment Management, LLC holds $750,511,239 across 12 Drug Manufacturers - General names. PFE ranks #7 (4.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
212,458 | $254,828,520 | |
| 2 | JNJ |
Johnson & Johnson
|
550,760 | $139,876,517 | |
| 3 | ABBV |
AbbVie Inc.
|
409,814 | $103,125,594 | |
| 4 | MRK |
Merck & Co., Inc.
|
565,110 | $72,616,635 | |
| 5 | AMGN |
Amgen Inc
|
138,472 | $50,143,480 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
284,053 | $35,887,256 | |
| 7 | PFE |
Pfizer Inc
This page
|
1,303,824 | $31,396,081 | |
| 8 | AZN |
Astrazeneca PLC
|
149,538 | $28,355,395 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $31,396,081 | 1,303,824 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $37,303,044 | 1,328,456 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $33,936,957 | 1,362,930 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $35,942,546 | 1,410,618 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $35,113,773 | 1,448,588 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $37,299,973 | 1,471,980 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $39,795,689 | 1,500,026 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $42,645,260 | 1,473,575 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $42,293,001 | 1,511,544 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $36,691,050 | 1,322,200 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $39,465,879 | 1,370,819 | Shares | Defined | 2024-04-22 | |
| 2023-09-30 | $46,326,217 | 1,396,630 | Shares | Defined | 2024-05-09 | |
| 2023-06-30 | $52,563,026 | 1,433,016 | Shares | Defined | 2024-04-29 | |
| 2023-03-31 | $59,139,477 | 1,449,497 | Shares | Defined | 2024-05-09 | |
| 2022-12-31 | $75,161,496 | 1,466,852 | Shares | Defined | 2024-05-10 | |
| 2022-09-30 | $65,228,918 | 1,490,606 | Shares | Defined | 2024-05-10 | |
| 2022-06-30 | $79,299,378 | 1,512,481 | Shares | Defined | 2024-05-10 | |
| 2022-03-31 | $79,036,068 | 1,526,677 | Shares | Defined | 2024-05-10 | |
| 2021-12-31 | $73,229,026 | 1,240,119 | Shares | Defined | 2024-05-17 | |
| 2021-09-30 | $54,464,982 | 1,266,333 | Shares | Defined | 2024-05-17 | |
| 2021-06-30 | $50,821,926 | 1,297,802 | Shares | Defined | 2024-05-17 | |
| 2021-03-31 | $48,154,995 | 1,329,147 | Shares | Defined | 2024-05-17 | |
| 2020-12-31 | $49,689,414 | 1,349,889 | Shares | Defined | 2024-05-24 | |
| 2020-09-30 | $51,707,092 | 1,408,914 | Shares | Defined | 2024-05-24 | |
| 2020-06-30 | $47,506,511 | 1,452,797 | Shares | Defined | 2024-05-24 | |
| 2020-03-31 | $46,560,603 | 1,426,491 | Shares | Defined | 2023-07-12 | |
| No filing history on record for this holder in this stock. | ||||||